Physician profile
James B Duke
NPI 1619958212
$55,007.98
in general payments reported to CMS, 2019-2025
11 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $2,941 · 2021: $9,407 · 2022: $3,803 · 2023: $5,840 · 2024: $1,875 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $8,948 · Consulting Fee: $8,250 · Food and Beverage: $1,028 · Travel and Lodging: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $8,948.26 |
| Consulting Fee | $8,250.00 |
| Food and Beverage | $1,027.90 |
| Travel and Lodging | $477.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $52,684.37 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $870.57 | 2019-2025 | Oxford, Mymobility Platform |
| Pixee Medical INC. | $270.61 | 2025 | |
| Advita Ortho, LLC | $250.00 | 2025 | |
| Depuy Synthes Sales INC. | $199.13 | 2019-2023 | Actis |
| Baudax Bio INC. | $178.19 | 2021-2022 | |
| Stryker Corporation | $132.20 | 2019 | |
| Endo Pharmaceuticals INC. | $131.35 | 2021 | |
| Novosource, LLC | $127.33 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $95.25 | 2019 | |
| Ortho Development Corporation | $68.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Duke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.